Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
07/2003
07/30/2003EP0837694B1 Leptospira membrane proteins
07/30/2003CN1433477A Method of achieving persistent transgene expression
07/30/2003CN1433474A Regulaed antigen delivery system (RADS) involving bacteria
07/30/2003CN1433469A Therapeutically useful synthetic oligonucleotides
07/30/2003CN1433466A MASP-3, complement-fixing enzyme, and uses for it
07/30/2003CN1433424A 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens
07/30/2003CN1433423A Mono and disaccharide derivatives
07/30/2003CN1433416A N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamideinhibitors of cyclin dependent kinases
07/30/2003CN1433414A Benzazole derivatives and their use as JNK modulators
07/30/2003CN1433412A Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
07/30/2003CN1433411A Chemical compounds
07/30/2003CN1433408A Aminothiazole inhibitors of cyslin dependent kinases
07/30/2003CN1433407A Bis-arylsulfones
07/30/2003CN1433405A Quinazoline compounds
07/30/2003CN1433396A Pharmaceutical compounds
07/30/2003CN1433323A 椅子 Chair
07/30/2003CN1433318A Vascular endothelial growth factor-2
07/30/2003CN1432374A Kidney asthenia treating medicine and its prepn process
07/30/2003CN1116305C Peptide derivatives
07/30/2003CN1116304C Organic compound
07/30/2003CN1116293C Preparation of dihydromyricetrin
07/30/2003CN1116288C Urea derivatives as inhibitors of inosine-5'-phospho-dehydrogenase
07/30/2003CN1116037C Use of flupirtin for prevention and treatment of disease which are associated with damage to haemopoietic cell system
07/30/2003CN1116036C Medicinal composition containing dihydroaremisine for treating rosacea and photosensitive diseases
07/29/2003US6600059 Protecting cells from injury due to intrinsic membrane lysis, oxidation and/or invasion by destructive agents. Even more particularly, the present invention provides compositions and methods for treating or prophylactically inhibiting
07/29/2003US6600038 Carbamoyl tetrahydropyridine derivatives
07/29/2003US6600030 Nucleotide sequences which code binding protein for use in diagnosis and treatment of asthma, arthritis, Crohn's and Grave's diseases and cystic fibrosis
07/29/2003US6599938 Optionally substituted Schiff base condensation products comprising an amino acid component and a benzaldehyde component, that have MIF (macrophage migration inhibitory factor) antagonist activity
07/29/2003US6599910 Substituted triazole compounds
07/29/2003US6599908 Fused polycyclic 2-aminopyrimidine derivatives
07/29/2003US6599901 Pyridone substituted benzothiazole derivatives
07/29/2003US6599875 IL-6 antagonist peptides
07/29/2003US6599727 Human poly (ADP-ribose) polymerase 2 materials and methods
07/29/2003US6599706 Recombinant PR-3 and assays employing the same
07/29/2003US6599535 Bioavailability of drug substance, are convenient to administer, and are stable
07/29/2003US6599528 Mechanically stable pharmaceutical presentations form containing liquid or semisolid surface-active substances
07/29/2003US6599507 Composition for the treatment of immune deficiencies and methods for its preparation and use
07/29/2003US6599506 Inhibiting integrin-associated diseases; rejection of transplanted organs, allergies, and autoimmune diseases
07/29/2003US6599502 Intracellular delivery vehicles
07/29/2003US6599501 Immunomodulators
07/29/2003US6599499 Uses of diterpenoid triepoxides as an anti-proliferative agent
07/29/2003CA2272417C Adjuvant for transcutaneous immunization
07/29/2003CA2189971C Vaccine for moraxella catarrhalis
07/29/2003CA2185036C Use of a non photosynthetic filamentous bacteria extract and composition containing the same
07/29/2003CA2180119C The composition containing snapping turtle and tortoise, the preparation and the use thereof
07/29/2003CA2078379C Method of treating immunoinflammatory disease
07/29/2003CA2076555C Pharmaceuticals for the treatment of rejection reactions in organ transplantations
07/29/2003CA2056065C Preparation of 3-alkylated indoles
07/29/2003CA2054473C Novel 3-cycloalkyl-propanamides, their tautomers and salts, process for their preparation, application as medicines and compositions containing them
07/24/2003WO2003060521A2 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation
07/24/2003WO2003060149A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
07/24/2003WO2003060143A2 Efficient protein expression system
07/24/2003WO2003060142A2 Compositions and methods for controlled release
07/24/2003WO2003060090A2 Novel cytokine zcytor17 ligand
07/24/2003WO2003060085A2 Mammalian neural stem cells, compositions and uses thereof
07/24/2003WO2003060082A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
07/24/2003WO2003060080A2 Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them
07/24/2003WO2003060072A2 Recombinant polypeptides
07/24/2003WO2003059950A1 Ifnar2 mutants, their production and use
07/24/2003WO2003059941A1 Biomolecule transduction motif mph-1-btm and the use thereof
07/24/2003WO2003059940A1 Biomolecule transduction motif sim-2-btm and the use thereof
07/24/2003WO2003059924A1 Novel binding epitopes for helicobacter pylori and use thereof
07/24/2003WO2003059899A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
07/24/2003WO2003059898A2 Eponemycin and epoxomicin analogs and uses thereof
07/24/2003WO2003059893A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
07/24/2003WO2003059891A1 Substituted pyridazinones as inhibitors of p38
07/24/2003WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
07/24/2003WO2003059873A1 Potassium channel modulators
07/24/2003WO2003059380A2 Oral vaccination
07/24/2003WO2003059366A1 Skin perparation for external use containing purpuricenus temminckii frass as the active ingredient
07/24/2003WO2003059353A1 Tyrosyl derivatives and their use as p2x7 receptor modulators
07/24/2003WO2003059294A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
07/24/2003WO2003059282A2 Human monoclonal antibodies against cd30
07/24/2003WO2003059276A2 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
07/24/2003WO2003059269A2 Acridone inhibitors of impdh enzyme
07/24/2003WO2003059264A2 Methods for the induction of professional and cytokine-producing regulatory cells
07/24/2003WO2003059255A2 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
07/24/2003WO2003059245A2 Method of treating asthma
07/24/2003WO2003045333A3 Treatment of hyperproliferative diseases using active vitamin d analogues
07/24/2003WO2003043572A3 Methods and compositions related to irm compounds and toll-like receptor pathways
07/24/2003WO2003032918A3 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors
07/24/2003WO2003032910A3 Carbinols for the treatment of neuropathic dysfunction
07/24/2003WO2003018612A3 Extracellular messengers
07/24/2003WO2003011895A3 Compositions and methods for modulation of immune responses
07/24/2003WO2003006645A3 Method and composition for inhibiting heparanase activity
07/24/2003WO2002100325A3 Polyvalent nanoparticles
07/24/2003WO2002060942A3 Protein modification and maintenance molecules
07/24/2003WO2002059323A3 Aminoacyl trna synthetases
07/24/2003WO2002030457A9 Microbes having an attenuating mutation comprising a transcription terminator
07/24/2003US20030140358 Transgenic mammal coding serine protease inhibitor which is expressed in mammary gland tissue and products for treating immunosuppression disorders and angioedema
07/24/2003US20030139607 Antiarrhythmic agents, treating cardiovascular disorders, infarct prophylaxis, angina pectoris, shock, stroke, transplant organ surgery
07/24/2003US20030139597 Novel Cyclic hydroxamic acid as metalloproteinase inhibitors
07/24/2003US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening
07/24/2003US20030139584 Tumor necrosis factor Receptor-Associated Factor (TRAF) protein-interacting hereditary multiple extoses (TREX) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents
07/24/2003US20030139466 Autoimmune diseases; administering a photoactive material to blood
07/24/2003US20030139462 Antiinflammatory agents; autoimmune disease; antiarthritic agents
07/24/2003US20030139452 Pyrazole-derived kinase inhibitors and uses thereof
07/24/2003US20030139446 Reacting with acid mixed with solvent; salt formation
07/24/2003US20030139441 Sulfonamido ether substituted imidazoquinolines
07/24/2003US20030139439 Uses of diterpenoid triepoxides as an anti-proliferative agent
1 ... 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 ... 1172